Their result showed CABG to be associated with a higher rate of stroke without statistically significance.[6] However, when the same outcome was compared in patients with ITDM and noninsulin-treated T2DM (NITDM), a significantly higher rate of stroke was associated with insulin therapy.[23] This current analysis only showed an insignificantly high rate of stroke observed among patients with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.